Viatris Announces Approval of WAKIX® (Pitolisant) in Japan
Viatris · Product launch · September 16, 2026
Japan's Ministry of Health, Labour and Welfare approved WAKIX for treating narcolepsy and excessive daytime sleepiness related to obstructive sleep apnea syndrome. It is the first histamine H3 receptor antagonist approved in Japan for these conditions.
AntSpace’s summary of Viatris’s own announcement: read the original.